Nplate® is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with immune thrombocytopenia (ITP) who have had an insufficient corticosteroids, immunoglobulins, or splenectomy.Nplate® is indicated for the treatment of thrombocytopenia in pediatric patients 1 year of age and older with ITP for at least 6 months who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
Nplate® is not indicated for the treatment of thrombocytopenia due to myelodysplastic syndrome (MDS) or any cause of thrombocytopenia other than ITP. Nplate® should be used only in patients with ITP whose degree of thrombocytopenia
and clinical condition increase the risk for bleeding. Nplate® should not be used in an attempt to normalize platelet counts.
Attention: Effective 1/01/2025, Nplate® Has A New HCPCS Code ("J-Code") and Dose Descriptor ("Billing/Service Units")
$0 OOP costs for Nplate®2
$0 OOP costs for
Oral ITP medications2
*Based on an analysis from 2021 to 2022 for Commercial and Medicare patient claims combined. Oral OOP percent is a weighted average claim for eltrombopag, avatrombopag, and fostamatinib disodium hexahydrate.2
OOP, out-of-pocket.
We're right here,
right when you need us
Personalized support that you and your patients can count on across Amgen therapies.
Connect with us live:
Call 866-264-2778
Monday through Friday — 9:00 AM to 8:00 PM ET
HCP Support Center
Our Amgen® SupportPlus Representatives can assist with issues around patient coverage, prior authorizations, co-pay programs, and more.
Benefits Verification
Prior Authorization Requirements
Amgen SupportPlus Customer Portal
Visit myAmgenPortal.com to register and submit forms online
Field Reimbursement Specialists
A Field Reimbursement Specialist can provide coverage and access resources to support your patients.
Contact your Field Reimbursement Specialist for support that includes:
Financial Support
We know every patient has unique needs. And we’re here to provide financial support information and resources, regardless of their current financial situation or what type of insurance they have.
Learn more about how Amgen SupportPlus can help your patients access their prescribed medication. Visit AmgenSupportPlus.com to learn more.
Amgen® SupportPlus Co-Pay Program
The Amgen SupportPlus Co-Pay Program may help eligible patients with private or commercial insurance lower their out-of-pocket costs.
Encourage your patients with private or commercial insurance to check eligibility and enroll.
*Eligibility criteria and program maximums apply. See AmgenSupportPlus.com/Copay for full Terms and Conditions.
Amgen® Nurse Partners
Amgen Nurse Partners† can offer support and provide information about resources to help patients access their prescribed medication.
Amgen Nurse Partners can provide support, including:
Patients can connect with an Amgen Nurse Partner by enrolling in Amgen SupportPlus in two ways:
†Amgen Nurse Partners are only available to patients that are prescribed certain Amgen products. They are not part of your patient’s treatment team and do not provide medical advice, nursing, or case management services. Amgen Nurse Partners will not inject patients with Amgen medications. Patients should always consult their healthcare provider regarding medical decisions or treatment concerns.
Amgen Therapy Locator™
Use this searchable database to locate alternative injection sites where Nplate® can be administered to your patients*
*The information on this website is reported by independent third-party sites that administer or deliver treatment to patients. It is not comprehensive of all sites that handle the therapies listed, and Amgen does not confirm accuracy or otherwise endorse any of these sites.
Connect with us
Monday through Friday — 9:00 AM to 8:00 PM ET
Nplate® administration may increase the risk for development or progression of reticulin fiber formation within the bone marrow. This formation may improve upon discontinuation of Nplate®. In a clinical trial, one patient with ITP and hemolytic anemia developed marrow fibrosis with collagen during Nplate® therapy.
Nplate® is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult patients with immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Nplate® is indicated for the treatment of thrombocytopenia in pediatric patients 1 year of age and older with ITP for at least 6 months who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
Nplate® is not indicated for the treatment of thrombocytopenia due to myelodysplastic syndrome (MDS) or any cause of thrombocytopenia other than ITP. Nplate® should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding. Nplate® should not be used in an attempt to normalize platelet counts.
Please see full Prescribing Information and Medication Guide.
References: 1. Data on file, Amgen; [1]; 2024. 2. Data on file, Amgen; [2]; 2024. 3. Data on file, Amgen; Number of patients treated with Nplate® from launch through to June 2024; Updated 2024.